Tag: Rare disease treatment options

fda-approval-onis-rare-disease-therapy-lowers-triglycerides

FDA Approval: Ionis Rare Disease Therapy Lowers Triglycerides

Ionis Pharmaceuticals has achieved a significant milestone by obtaining FDA approval for their groundbreaking therapy, Tryngolza, designed to combat a rare and fatal genetic disease. This therapy targets patients suffering from familial chylomicronemia syndrome...